India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Efforts to streamline India's drug regulatory system into a single central authority may suffer a body blow as the parliamentary committee set up to study the proposed changes may recommend scrapping the new body. Top industry sources told PharmAsia News that the committee is not completely convinced about the advantages of having a Central Drug Authority